According to the Complaint, Odonate Therapeutics, Inc. is a pharmaceutical company that develops therapeutics for the treatment of cancer. The Company is focused on developing tesetaxel, an orally administered chemotherapy agent.
Recent Security Class Actions
According to the Complaint, Nano-X Imaging Ltd. purportedly develops and produces x-ray source technology for the medical imaging industry.
According to the Complaint, Nikola Corporation purports to operate as an integrated zero emissions transportation systems provider which designs and manufactures battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen fueling station infrastructure.
According to the Complaint, GOL Linhas Areas Inteligentes S.A. purports to provide air passenger transportation services in Brazil, the rest of South America, the Caribbean, and the United States.
According to the Complaint, Colony Credit Real Estate, Inc. is a commercial real estate (“CRE”) credit real estate investment trust (“REIT”) that purports to manage a diversified portfolio of CRE senior mortgage loans, mezzanine loans, preferred equity, debt securities, and net leased properties predominantly in the U.S.
According to the Complaint, Livongo Health, Inc. has created a unified platform that provides smart, cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications across multiple chronic conditions for its members.
According to the Complaint, Lexinfintech Holdings, LTD, through its subsidiaries, purports to operate as an online consumer finance platform for young professionals in the People’s Republic of China.
According to the Complaint, YayYo, Inc. purports to, through its subsidiaries, operate an online peer-to-peer booking platform that rents standard passenger vehicles to self-employed ridesharing drivers and manages a fleet of standard passenger vehicles to be rented directly to drivers in the ridesharing economy.
According to the Complaint, Harborside, Inc. purports to be a vertically-integrated cannabis company.
According to the Complaint, Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleotide platform.
